Biotechnology Market, By Technology (PCR, NanoBiotechnology, DNA Sequencing, Fermentation, Tissue Regeneration, and Cell-Based Assay), By Application (Bioservices, Biopharmacy, Bioindustrial, and Bio-agriculture) and Geography (NA, EU, APAC, and RoW) Analysis, Share, Trends, Size, & Forecast From 2014 2025
REPORT HIGHLIGHT
The biotechnology market is estimated to represent a global market of USD 403.8 billion by 2017 with growth rate of 10.9%.
Market Dynamics
Biotechnology industry covers the study of living organisms to develop or modify new products for a specific purpose. Increasing research and development activities coupled with rising investment by key players in this market is driving the market growth significantly. Furthermore, the growth is attributed to the favorable government initiatives to promote biotech field across the globe. As per the various research publications, currently, more than 250 biotechnology vaccines and products are commercially available and is projected to increase at a significant rate. On contrary, the high cost of biopharmaceuticals coupled with the strict regulatory environment has been acknowledged as a major restraining factor for this industry
Technology Takeaway
In terms of technology, the global biotechnology market is categorized as PCR, NanoBiotechnology, DNA Sequencing, Fermentation, Tissue Regeneration, Cell-Based Assay, and others. Of which, tissue regeneration segment achieved the highest share of the total market, accounted for more than USD 75 billion in 2017. It refers to the method of combining biological active molecule with scaffold/cells into functional tissue. Tissue engineering and regeneration exhibit strong potential in the skeletal reconstruction of large bone defects as well as gene-based therapies. Cartilage and artificial skin are some of the examples of tissue regeneration and engineered products approved by the U.S. FDA. Currently, several research activities are undergoing to develop high-throughput assays and instruments in order to reduce the complexity, time, and cost of tissue engineering. In addition to medical applications, non-therapeutic applications of this method include tissue chips that can be used to test toxicity and development of biosensors.
Application Takeaway
Application segment is divided into Bioservices, Biopharmacy, Bioindustrial, and Bio-agriculture. Biopharmacy captured the highest (almost 60% share through the study period) share of the global biotechnology industry. Further, this segment appears to be growing at a strong rate over the future period. The bio-agriculture application is estimated to grow at significant CAGR owing to the advancement in crop harvesting techniques coupled with the commercialization of biotech crops. For example, according to the International Service for the Acquisition of Agri-Biotech Applications, in 2016, around 18 million farmers have planted 185.1 million hectares of biotech crops were in 26 countries which were almost 110 fold increase compared to the 1.7 million hectares planting in 1996.
Regional Takeaway
Regionally, developed regions such as North America and Europe accounted for the highest share of the global industry. Increasing research and development activities coupled with growing demand for effective pharmaceuticals drive the regional growth. For example, as per the Pharmaceutical Research and Manufacturers Association (PhRMA), the U.S. firms conduct over half of the world’s R&D activities in the pharma sector and hold the intellectual property rights (IPR) on most of the new therapeutics.
Asia Pacific region is pegged to register a 15.6% growth rate in terms of value. A country such as India and China’s billion-plus population offers huge growth potential for biotechnology products and services. Moreover, increasing budgetary allocations for the biotech industry in these countries further provide a healthy platform for market growth. While the biotech industry is on a high growth trajectory in Asia Pacific countries, the overall market remains small in African countries owing to the fragile backbone of the country’s healthcare infrastructure and a shortage of skilled professionals.
Key Vendor Takeaway
Companies such as AstraZeneca, Biogen, Abbott, Merck, and Novartis AG are studies in detail along with the attributes such as company overview, financial performance, and key developments. Key companies are engaged in expanding their market presence through strategic mergers and acquisitions to capture large customer base. For instance, in August 2016, Novartis announced to the expansion of its biotechnology facility in Huningue, France. Such expansion has helped the company to boost its monoclonal antibody production by 70%.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2014 & 2016
- Base Year – 2017
- Estimated Year – 2018
- Projected Year – 2025
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Hospitals
- Government and Regional Agencies and Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY TECHNOLOGY
- PCR
- NanoBiotechnology
- DNA Sequencing
- Fermentation
- Tissue Regeneration
- Cell-Based Assay
- Others
MARKET, BY APPLICATION
- Bioservices
- Biopharmacy
- Bioindustrial
- Bio-agriculture
MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Rest of Europe
- Asia Pacific
- India
- China
- Rest of APAC
- Rest of the World
- Middle East and Africa
- Latin America
TABLE OF CONTENT
1. BIOTECHNOLOGY MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. BIOTECHNOLOGY KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. BIOTECHNOLOGY INDUSTRY STUDY
4.1. Porter’s Analysis
4.2. Market Attractiveness Analysis
4.3. Regulatory Framework Analysis
5. BIOTECHNOLOGY MARKET LANDSCAPE
5.1. Market Share Analysis
6. BIOTECHNOLOGY MARKET – BY TECHNOLOGY
6.1. Overview
6.2. Polymerase Chain Reaction
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.3. NanoBiotechnology
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.4. DNA Sequencing
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.5. Fermentation
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.6. Tissue Regeneration
6.6.1. Overview
6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.7. Cell-Based Assay
6.7.1. Overview
6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
6.8. Others (Chromatography etc.)
6.8.1. Overview
6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7. BIOTECHNOLOGY MARKET – BY APPLICATION
7.1. Overview
7.2. Bioservices
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.3. Biopharmacy
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.4. Bioindustrial
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
7.5. Bio-agriculture
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8. BIOTECHNOLOGY MARKET– BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.2.3. U.S.
8.2.3.1. Overview
8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.2.4. Canada
8.2.4.1. Overview
8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3. Europe
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3.3. France
8.3.3.1. Overview
8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3.4. Germany
8.3.4.1. Overview
8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.3.5. Rest of Europe
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4.3. China
8.4.3.1. Overview
8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4.4. India
8.4.4.1. Overview
8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.4.5. Rest of APAC
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.5. Rest of the World
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.5.3. Latin America
8.5.3.1. Overview
8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
8.5.4. Middle East and Africa
8.5.4.1. Overview
8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
9. KEY VENDOR ANALYSIS
9.1. AstraZeneca
9.1.1. Company Overview
9.1.2. SWOT Analysis
9.1.3. Key Developments
9.2. Biogen
9.2.1. Company Overview
9.2.2. SWOT Analysis
9.2.3. Key Developments
9.3. Abbott
9.3.1. Company Overview
9.3.2. SWOT Analysis
9.3.3. Key Developments
9.4. Merck
9.4.1. Company Overview
9.4.2. SWOT Analysis
9.4.3. Key Developments
9.5. Novartis AG
9.5.1. Company Overview
9.5.2. SWOT Analysis
9.5.3. Key Developments
*Client can request additional company profiling as per specific requirements
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. Abbreviations
11.3. Disclaimer
11.4. Contact Us
List of Tables
Table 1 List of Acronyms
Table 2 Key Market Facts, 2014 – 2025
Table 3 Market Drivers: Impact Analysis
Table 4 Market Restraint: Impact Analysis
Table 5 Market Opportunity: Impact Analysis
Table 6 PEST Analysis
Table 7 Porter’s Five Forces Analysis
Table 8 Company Market Share Analysis
Table 9 Global Biotechnology Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Billion)
Table 10 Biotechnology Market, by Technology, 2014 – 2025 (USD Billion)
Table 11 Biotechnology Market, by Application, 2014 – 2025 (USD Billion)
Table 12 Biotechnology Market, by Geography, 2014 – 2025 (USD Billion)
Table 13 North America Biotechnology Market, 2014 – 2025 (USD Billion)
Table 14 U.S. Biotechnology Market, 2014 – 2025 (USD Billion)
Table 15 Canada Biotechnology Market, 2014 – 2025 (USD Billion)
Table 16 Europe Biotechnology Market, 2014 – 2025 (USD Billion)
Table 17 France Biotechnology Market, 2014 – 2025 (USD Billion)
Table 18 Germany Biotechnology Market, 2014 – 2025 (USD Billion)
Table 19 Asia Pacific Biotechnology Market, 2014 – 2025 (USD Billion)
Table 20 China Biotechnology Market, 2014 – 2025 (USD Billion)
Table 21 India Biotechnology Market, 2014 – 2025 (USD Billion)
Table 22 Latin America Biotechnology Market, 2014 – 2025 (USD Billion)
Table 23 MEA Biotechnology Market, 2014 – 2025 (USD Billion)
List of Figures
Figure 1 Research Methodology
Figure 2 Research Process Flow Chart
Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
Figure 4 Regulatory Framework Analysis
Figure 5 Value Chain Analysis Analysis
Figure 6 Biotechnology Market, by Technolgy, 2014 – 2025 (USD Billion)
Figure 7 Biotechnology Market, by Application, 2014 – 2025 (USD Billion)
Figure 8 Biotechnology Market, by Geography, 2014 – 2025 (USD Billion)
